Micro-Doppler Radar: A Gold Standard Comparison (NCT05521126) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Micro-Doppler Radar: A Gold Standard Comparison
United States181 participantsStarted 2023-02-21
Plain-language summary
The purpose of this study is to see if the study team can use micro-Doppler signal (MDS) technology to determine if someone has had an anterior cruciate ligament (ACL) reconstruction. The investigators will do this by comparing the movement data from a group of people who have had the surgery with a group who has not had the surgery to see if the micro-Doppler radar technology can accurately and predictably tell the difference.
Who can participate
Age range
18 Years – 40 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
High risk cohort
* age 18-40
* history of ACL reconstruction
* no current musculoskeletal injuries
* ACL repair between 9 and 24 months prior to recruitment
Control cohort
* age 18-40
* never had lower extremity surgery
Exclusion Criteria:
High risk cohort
* age \<18 or \>40
* pregnancy
* institutionalization
* history of cerebral vascular accident
* unable to provide informed consent
* inability to perform study activities
* history of hip or knee replacement
* inability to walk or jump without a limp
* current neuromuscular disease
* any surgery in the last 6 months
Control cohort
* age \< 18 or \> 40
* pregnancy
* institutionalization
* history of Cerebral Vascular Accident
* unable to provide informed consent
* inability to perform study activities
* history of knee or hip replacement
* inability to walk or jump without a limp
* current neuromuscular disease
* history of lower extremity surgery
* any surgery in the last 6 months
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
accuracy and predictability of MDS differentiation between ACL repair and control group